Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 870.90
+7.60 (0.88%)
At close: Feb 20, 2026
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 262.03 million as of February 20, 2026. Its market cap has decreased by -4.18% in one year.
Market Cap
262.03M
Enterprise Value
215.57M
Revenue
n/a
Ranking
n/a
PE Ratio
235.56
Stock Price
870.90
Market Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 262.03M, a decrease of -78.27%. That is a compound annual growth rate of -30.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 262.03M | 43.80% |
| Dec 31, 2025 | 182.22M | -32.71% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
| Dec 15, 2021 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 124.25B |
| Danel (Adir Yeoshua) | 2.69B |
| Kamada | 1.58B |
| BrainsWay | 1.51B |
| Novolog (Pharm-Up 1966) | 605.90M |
| Bonus BioGroup | 589.80M |
| Geffen Residence & Renewal | 267.24M |
| Golden House | 162.46M |